← SynDRA
EPINASTINE
SynDRA canonical compound SYN0003756 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HRH2 |
|---|
| Mechanism of action | Histamine receptor antagonist |
|---|
| Indication | conjunctivitis |
|---|
| Disease area | ophthalmology |
|---|
All known targets
- HRH1
- HRH2
- ABCB1
- ADRA1A
- ADRA2A
- HTR2A
- KCNH2
- SLC22A2
- SLC47A1
- SLC47A2
Mechanisms of action (all sources)
- Histamine receptor antagonist
- HRH1 ANTAGONIST
- Histamine H1 receptor antagonist
Drug classes
- Adrenergic Agonists
- Histamine H1 Receptor Antagonists
- Histamine-1 Receptor Inhibitor
- Histamine Agents
- Histamine Antagonists
- Histamine H1 Antagonists
- Neurotransmitter Agents
- Adrenergic Receptor Agonist
ATC classes
- S01G · DECONGESTANTS AND ANTIALLERGICS
- R06A · ANTIHISTAMINES FOR SYSTEMIC USE
Cross-references
Synonyms
- alesion
- (+/-)-Epinastine
- epinastine hydrochloride
- epinastine HCl
- Epinastina
- Purivist
- WAL-801
- Epinastinum
- Epinastina [Spanish]
- Epinastine [INN]
- Epinastinum [Latin]
- WAL 80
- WAL 801
- WAL 801CL
- Elestat (TN)
- Epinastine (INN)
- Purivist (TN)
- Relestat (TN)
- WAL-80 Cl
- (+-)-Epinastine
- 3-Amino-9,13b-dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepine
- 3-amino-9,13b-dihydro-1H-benz(c,f)imidazo(1,5a)azepine
- 9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine
- Elestat
- CHEMBL1106
- Q13WX941EF
- CHEBI:51032
- Relestat
- 3-Amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine
- Epinastinehydrochloride
- 2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine
- 1H-Dibenz[c,f]imidazo[1,5-a]azepin-3-amine, 9,13b-dihydro-
- Epinastine [INN:BAN]
- NCGC00165791-02
- UNII-Q13WX941EF
- 9,13b-Dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3-amine
- 9,13B-DIHYDRO-1H-DIBENZ(C,F)IMIDAZO(1,5-A)AZEPIN-3-AMINE
- 1H-DIBENZ(C,F)IMIDAZO(1,5-A)AZEPIN-3-AMINE, 9,13B-DIHYDRO-
Look up EPINASTINE in the interactive SynDRA portal →